Save for a very brief while at the start, the Switzerland market languished in negative territory on Friday, due largely to profit taking at several counters amid a lack of fresh triggers.
The benchmark SMI, which edged up to 14,501.16 in early trades, fell to a low of 14,342.33 before settling at 14,390.67, losing 84.46 points or 0.58%.
Galderma Group ended down 3.1%. Roche, Lonza Group and Richemont shed about 2%, 1.8% and 1.6%, respectively.
Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial – No Payment Required
Swiss Market Ends Moderately Lower
2026-08-14 17:51:07
